2025-12-13 - Analysis Report
Okay, here's a breakdown of the BlackRock (BLK) data, including analysis and summaries.

**0. Introduction**

This report analyzes the current state of BlackRock (BLK) stock, considering returns, risk indicators, news, analyst opinions, and financial performance. We will compare its performance against the S&P 500 (VOO) and provide a comprehensive summary.

**1. Return Rate Comparison**

*   **Ticker:** BLK
*   **Company Overview:** BlackRock Inc. is a multinational investment management corporation.
*   **BLK Cumulative Return:** 58.19%
*   **VOO Cumulative Return:** 102.37%
*   **Divergence:** -43.89% (Current)
*   **Divergence Range:** Max: 32.1, Min: -49.6
*   **Relative Divergence:** 7.0

**Analysis:** BlackRock has significantly underperformed the S&P 500 over the analyzed period. The current divergence of -43.89% indicates substantial underperformance. The relative divergence of 7.0 suggests the current divergence is near the lower end of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 48.0% | 61.2% | 20.0% | 0.1 | 80.1 |
| 2016-2018  | 7.0% | 68.1% | -8.0% | 0.1 | 61.3 |
| 2017-2019  | 18.0% | 69.4% | -5.0% | -0.4 | 78.4 |
| 2018-2020  | -2.0% | 81.8% | -25.0% | -0.3 | 112.5 |
| 2019-2021  | 67.0% | 81.8% | 20.0% | -0.2 | 142.8 |
| 2020-2022  | -2.0% | 81.8% | -1.0% | 2.2 | 110.5 |
| 2021-2023  | 6.0% | 76.8% | 4.0% | 3.0 | 126.6 |
| 2022-2024  | 24.0% | 78.6% | 3.0% | 3.1 | 159.9 |
| 2023-2025  | 24.0% | 78.6% | -43.0% | 1.3 | 169.0 |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Volatility in growth.  Periods of strong growth (2015-2017, 2019-2021) are offset by periods of stagnation or decline.
*   **MDD (Maximum Drawdown):** High MDD consistently indicates significant risk.
*   **Alpha:** Mixed alpha values indicate BLK's performance sometimes exceeds and sometimes falls short of what would be expected based on its beta. The recent negative alpha (-43%) is a major concern.
*   **Beta:** Beta varies, indicating BLK's sensitivity to market movements.  High beta above 1 after 2020-2022 means that BlackRock has become very sensitive to the market and is fluctuating more than the market.
*   **Cap(B):** BlackRock's capitalization has generally increased, demonstrating growth in the size of the company.

**2. Recent Stock Price Fluctuations**

*   **Close:** 1083.36
*   **Last Market:** Price: 1089.09, Previous Close: 1101.84, Change: -1.16
*   **5-day SMA:** 1072.89
*   **20-day SMA:** 1047.29
*   **60-day SMA:** 1104.91

**Analysis:** The stock price is currently below its 60-day SMA but above its 5-day and 20-day SMAs. This suggests a short-term upward trend after a longer-term decline. The slight decline in the last market indicates some recent selling pressure.

**3. RSI, PPO, and Expected Return**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment)
*   **RSI:** 70.68 (Approaching Overbought)
*   **PPO:** 0.79
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) Dividend_5.21 (Cash Ratio: 0% on 2025-12-05)
*   **Recent (20 days) relative divergence change:** 7.0 (+): 단기상승 (Short-term rise)
*   **Last Market Change:** -1.16 (Fluctuation Issue)
*   **Expected Return (%):** -118.3% (Excess return compared to S&P 500 if invested long-term)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI indicates the stock is approaching overbought territory, potentially signaling a pullback.
*   The PPO being positive suggests the price is generally trending upwards.
*   The hybrid signal suggests to buy 90% of cash.
*   The negative expected return is a significant red flag, suggesting analysts don't predict BLK to beat S&P 500 returns in the long term.

**4. Recent News & Significant Events**

*   **[2025-12-12] Barclays Lowers Price Target for BlackRock (BLK) to USD 1340.00:** A lowered price target could indicate concerns about BlackRock's future performance.
*   **[2025-12-10] Why BlackRock (BLK) Outpaced the Stock Market Today:** This suggests a positive day for BlackRock, but it's important to analyze the underlying reasons.
*   **[2025-12-11] BlackRock (NYSE:BLK) Stock Rises After New ETF Launch Debut:**  A new ETF launch is generally a positive catalyst, suggesting innovation and growth.
*   **[2025-12-12] BlackRock (BLK) Initiated with a Hold at UBS:** A "Hold" rating suggests a neutral outlook.
*   **[2025-09-14] Here's How Many Shares of BlackRock (BLK) Stock You Should Own to Get $1,000 in Yearly Dividends:** Highlights BlackRock's dividend payout to investors.
*   **[2025-11-28] Uneven economy will drive investors' Black Friday stock picking:** Suggests BlackRock is a stock considered in the context of the broader economic picture.

**Analysis:** The news is mixed. While the ETF launch and a day of outperformance are positive, the lowered price target and "Hold" rating from UBS are concerning.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.71)
*   **Opinions:** 15
*   **Target Price (avg/high/low):** 1317.93 / 1486.00 / 1170.00

**Analysis:** Despite the recent negative news, the overall analyst consensus is "Buy."  The average target price is significantly higher than the current price, suggesting potential upside. However, the lowered price target from Barclays highlights that not all analysts are equally optimistic. The lack of Recent Rating Changes (no tickers listed) makes it difficult to understand the time-series trend in analyst opinions

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출    |
|------------|-------|---------|
| 2024-08-06 | 10.07 | 4.80 B$ |
| 2024-05-07 | 10.58 | 4.73 B$ |
| 2023-11-06 | 10.75 | 4.52 B$ |
| 2023-08-04 | 9.13  | 4.46 B$ |
| 2024-08-06 | 9.13  | 4.46 B$ |

**Analysis:** EPS (Earnings Per Share) and Revenue have been fluctuating. There was a dip in EPS in August 2023, but they have generally been trending upwards. The revenue also shows a general increasing trend. Note: there are two "2024-08-06" entries that must be corrected, and this impacts overall observations.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $6.51B  | 45.94%        |
| 2025-06-30 | $5.42B  | 47.87%        |
| 2025-03-31 | $5.28B  | 47.88%        |
| 2024-12-31 | $5.68B  | 49.25%        |
| 2024-09-30 | $5.20B  | 51.13%        |

**Capital and Profitability**

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-09-30 | $55.52B  | 2.38%  |
| 2025-06-30 | $49.14B  | 3.24%  |
| 2025-03-31 | $48.04B  | 3.14%  |
| 2024-12-31 | $47.49B  | 3.52%  |
| 2024-09-30 | $41.18B  | 3.96%  |

**Analysis:**

*   **Revenue:** Shows growth, reaching $6.51B in the most recent quarter.
*   **Profit Margin:**  While still strong, the profit margin has decreased slightly from 51.13% to 45.94% over the past year.
*   **Equity:**  Growing, indicating a strengthening financial base.
*   **ROE (Return on Equity):** ROE has decreased, which, coupled with the drop in profit margin, could indicate challenges in generating profit from equity.

**7. Comprehensive Analysis (Summary)**

BlackRock (BLK) presents a mixed picture. While the company demonstrates growth in revenue, equity, and capitalization, it has significantly underperformed the S&P 500. The decreasing profit margin and ROE raise concerns, as does the negative long-term expected return compared to the S&P 500. Recent news and analyst opinions are contradictory, with a "Buy" consensus offset by a lowered price target and a "Hold" rating. The stock is approaching overbought conditions (RSI), suggesting a potential pullback.

**Overall Recommendation:** Given the underperformance relative to the S&P 500, the negative expected return, and the mixed analyst opinions, a cautious approach to investing in BLK is warranted. Further investigation into the factors driving the lower profit margin and ROE is recommended before making a decision. The ETF launch is a positive catalyst, but it's not enough to outweigh the other concerns. Consider the high MDD values in the Alpha/Beta analysis, which signal high risk.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.